AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Medicinal research reviews

Results: 1-25/204

Authors: Hamann, L Norman, BH Flynn, D
Citation: L. Hamann et al., Editorial: Fourth Winter Conference on Medicinal and Bioorganic Chemistry.Part 2, MED RES REV, 21(6), 2001, pp. 485-486

Authors: Toogood, PL
Citation: Pl. Toogood, Cyclin-dependent kinase inhibitors for treating cancer, MED RES REV, 21(6), 2001, pp. 487-498

Authors: Traxler, P Bold, G Buchdunger, E Caravatti, G Furet, P Manley, P O'Reilly, T Wood, J Zimmermann, J
Citation: P. Traxler et al., Tyrosine kinase inhibitors: From rational design to clinical trials, MED RES REV, 21(6), 2001, pp. 499-512

Authors: Willson, TM Jones, SA Moore, JT Kliewer, SA
Citation: Tm. Willson et al., Chemical genomics: Functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism, MED RES REV, 21(6), 2001, pp. 513-522

Authors: Egner, U Heinrich, N Ruff, M Gangloff, M Mueller-Fahrnow, A Wurtz, JM
Citation: U. Egner et al., Different ligands-different receptor conformations: Modeling of the hER alpha LBD in complex with agonists and antagonists, MED RES REV, 21(6), 2001, pp. 523-539

Authors: Jones, AB
Citation: Ab. Jones, Peroxisome proliferator-activated receptor (PPAR) modulators: Diabetes andbeyond, MED RES REV, 21(6), 2001, pp. 540-552

Authors: Flynn, D
Citation: D. Flynn, Editorial: Fourth Winter Conference on Medicinal and Bioorganic Chemistry.Part 1, MED RES REV, 21(5), 2001, pp. 355-355

Authors: Boger, DL
Citation: Dl. Boger, Vancomycin, teicoplanin, and ramoplanin: Synthetic and mechanistic studies, MED RES REV, 21(5), 2001, pp. 356-381

Authors: Jang, GR Harris, RZ Lau, DT
Citation: Gr. Jang et al., Pharmacokinetics and its role in small molecule drug discovery research, MED RES REV, 21(5), 2001, pp. 382-396

Authors: Kumar, GN Surapaneni, S
Citation: Gn. Kumar et S. Surapaneni, Role of drug metabolism in drug discovery and development, MED RES REV, 21(5), 2001, pp. 397-411

Authors: Thompson, TN
Citation: Tn. Thompson, Optimization of metabolic stability as a goal of modern drug design, MED RES REV, 21(5), 2001, pp. 412-449

Authors: Mierke, DF Giragossian, C
Citation: Df. Mierke et C. Giragossian, Peptide hormone binding to G-protein-coupled receptors: Structural characterization via NMR techniques, MED RES REV, 21(5), 2001, pp. 450-471

Authors: Shacham, S Topf, M Avisar, N Glaser, F Marantz, Y Bar-Haim, S Noiman, S Naor, Z Becker, OM
Citation: S. Shacham et al., Modeling the 3D structure of GPCRs from sequence, MED RES REV, 21(5), 2001, pp. 472-483

Authors: Myung, J Kim, KB Crews, CM
Citation: J. Myung et al., The ubiquitin-proteasome pathway and proteasome inhibitors, MED RES REV, 21(4), 2001, pp. 245-273

Authors: Wallin, R Wajih, N Greenwood, GT Sane, DC
Citation: R. Wallin et al., Arterial calcification: A review of mechanisms, animal models, and the prospects for therapy, MED RES REV, 21(4), 2001, pp. 274-301

Authors: Singh, MM
Citation: Mm. Singh, Centchroman, a selection estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders, MED RES REV, 21(4), 2001, pp. 302-347

Authors: Mager, PP
Citation: Pp. Mager, The active site of HIV-1 protease, MED RES REV, 21(4), 2001, pp. 348-353

Authors: Straus, DS Glass, CK
Citation: Ds. Straus et Ck. Glass, Cyclopentenone prostaglandins: New insights on biological activities and cellular targets, MED RES REV, 21(3), 2001, pp. 185-210

Authors: Nicholson, NS Abood, NA Panzer-Knodle, SG Frederick, LG Page, JD Salyers, AK Suleymanov, OD Szalony, JA Taite, BB Anders, RJ
Citation: Ns. Nicholson et al., Orbofiban: An orally active GPIIB/IIIa platelet receptor antagonist, MED RES REV, 21(3), 2001, pp. 211-226

Authors: Martinez, A Castro, A Gil, C Perez, C
Citation: A. Martinez et al., Recent strategies in the development of new human cytomegalovirus inhibitors, MED RES REV, 21(3), 2001, pp. 227-244

Authors: Wang, BH Thakker, DR
Citation: Bh. Wang et Dr. Thakker, Editorial announcement, MED RES REV, 21(2), 2001, pp. 103-104

Authors: Cristalli, G Costanzi, S Lambertucci, C Lupidi, G Vittori, S Volpini, R Camaioni, E
Citation: G. Cristalli et al., Adenosine deaminase: Functional implications and different classes of inhibitors, MED RES REV, 21(2), 2001, pp. 105-128

Authors: Barone, FC Irving, EA Ray, AM Lee, JC Kassis, S Kumar, S Badger, AM Legos, JJ Erhardt, JA Ohlstein, EH Hunter, AJ Harrison, DC Philpott, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia, MED RES REV, 21(2), 2001, pp. 129-145

Authors: Wang, Y
Citation: Y. Wang, The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis, MED RES REV, 21(2), 2001, pp. 146-170

Authors: Cignarella, A Paoletti, R Puglisi, L
Citation: A. Cignarella et al., Direct effects of estrogen on the vessel wall, MED RES REV, 21(2), 2001, pp. 171-184
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>